Molecular biology reports

How mTOR and AMPK signals relate to placental problems and preeclampsia, and how metformin may help

Updated

Abstract

Preeclampsia is associated with a shift towards increased AMPK activation and reduced mTORC1 activity in the placenta.

  • The physiological balance between mTORC1 and AMPK is crucial for proper trophoblast invasion and nutrition during normal pregnancy.
  • Chronic placental hypoxia and oxidative stress in preeclampsia disrupt this balance, leading to adverse effects on trophoblast function.
  • Increased anti-angiogenic factor production is a consequence of the altered mTOR/AMPK interaction in preeclampsia.
  • Low doses of AMPK activation may help restore metabolic balance, but higher doses, particularly with metformin, could further inhibit mTORC1 activity.
  • Targeting the mTOR/AMPK axis offers insights into preeclampsia mechanisms and potential therapies, although careful dosing of metformin is necessary.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

0 of 6
authors report competing interests
6 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free